Physician profile
Jasmine Sutton
NPI 1831892603
$318.57
in general payments reported to CMS, 2019-2025
9 companies · $41.36 in 2025
The $41.36 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $22.89 · 2023: $221 · 2024: $33.07 · 2025: $41.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $92.47 | 2023 | |
| Medline Industries Lp | $74.43 | 2024-2025 | Medline Industries, INC., Remedy Antifungal, Remedy Skin Protectant |
| Novo Nordisk INC | $44.31 | 2022-2023 | Rybelsus |
| Organon LLC | $31.44 | 2023 | Nexplanon |
| Almatica Pharma LLC | $17.96 | 2023 | Gralise, Sertraline Hcl, Loreev Xr |
| Astrazeneca Pharmaceuticals Lp | $15.26 | 2023 | Farxiga |
| Lilly USA, LLC | $15.12 | 2023 | Mounjaro |
| Tolmar, INC. | $14.19 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $13.39 | 2023 | Rexulti, Abilify Maintena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.